Pharmaceutical blister packaging is a common form of pharmaceutical packaging used to contain single doses of drugs. This form of packaging usually consists of a prefabricated plastic cavity made of blister and a foil or plastic backing covered with it, which protects the drug from contamination and damage from the external environment.
The advantages of pharmaceutical blister packaging are that it can effectively extend the shelf life of pharmaceuticals, maintain the quality and stability of pharmaceuticals, and have good resistance to moisture, oxidation and gas permeation.
Traditional pharmaceutical blister packaging usually uses a plastic cavity made of polyvinyl chloride (PVC) and an aluminum foil or plastic backing. However, in recent years, due to environmental and sustainability concerns, more and more pharmaceutical companies are using packaging made of recyclable materials, such as PET and PP, to replace traditional PVC/aluminum foil blister packaging.
The materials and manufacturing process of pharmaceutical blister packaging must comply with national and regional regulatory requirements, such as US FDA, EU CE and Chinese GMP.
To ensure the quality and safety of pharmaceutical products, pharmaceutical blister packaging must undergo rigorous testing and evaluation, including validation of manufacturing and packaging processes, drug stability testing, and various quality control tests.
The growth of the pharmaceutical blister packaging market is mainly driven by the demand from the pharmaceutical and medical device industries. The pharmaceutical blister packaging market is expected to continue its growth trend in the coming years due to the increasing demand from pharmaceutical companies for safety and sustainability of pharmaceutical packaging.
Overall, pharmaceutical blister packaging is a reliable, safe, and effective form of pharmaceutical packaging that offers pharmaceutical companies a wide range of options and flexibility to meet different pharmaceutical packaging needs. At the same time, with the increasing focus on environmental and sustainability issues, more recyclable, biodegradable and recyclable pharmaceutical blister packaging materials and solutions are likely to emerge in the future.